Bill Few Associates Inc. Buys Shares of 1,287 Cardinal Health, Inc. $CAH

Bill Few Associates Inc. bought a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 1,287 shares of the company’s stock, valued at approximately $216,000.

Several other institutional investors have also added to or reduced their stakes in CAH. MassMutual Private Wealth & Trust FSB lifted its position in Cardinal Health by 3.6% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company’s stock valued at $297,000 after purchasing an additional 62 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its position in Cardinal Health by 0.4% during the second quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 17,805 shares of the company’s stock valued at $2,991,000 after purchasing an additional 69 shares in the last quarter. Perigon Wealth Management LLC lifted its position in Cardinal Health by 3.2% during the second quarter. Perigon Wealth Management LLC now owns 2,314 shares of the company’s stock valued at $389,000 after purchasing an additional 72 shares in the last quarter. Community Bank & Trust Waco Texas lifted its position in Cardinal Health by 1.3% during the second quarter. Community Bank & Trust Waco Texas now owns 5,598 shares of the company’s stock valued at $940,000 after purchasing an additional 74 shares in the last quarter. Finally, Yarger Wealth Strategies LLC lifted its position in Cardinal Health by 4.3% during the second quarter. Yarger Wealth Strategies LLC now owns 1,835 shares of the company’s stock valued at $308,000 after purchasing an additional 76 shares in the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Trading Down 0.2%

NYSE:CAH opened at $156.86 on Monday. The company has a market capitalization of $37.27 billion, a P/E ratio of 24.32, a P/E/G ratio of 1.33 and a beta of 0.71. Cardinal Health, Inc. has a 12 month low of $106.98 and a 12 month high of $168.44. The business’s 50-day moving average is $152.09 and its 200 day moving average is $151.31.

Cardinal Health (NYSE:CAH) last posted its earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. The company had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm’s revenue for the quarter was up .5% on a year-over-year basis. During the same period in the previous year, the business earned $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, research analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date is Wednesday, October 1st. Cardinal Health’s payout ratio is currently 31.63%.

Insider Buying and Selling

In related news, CEO Stephen M. Mason sold 41,575 shares of the business’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $6,187,191.50. Following the sale, the chief executive officer directly owned 26,085 shares in the company, valued at approximately $3,881,969.70. The trade was a 61.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Ola M. Snow sold 28,151 shares of the business’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total value of $4,192,809.94. Following the completion of the sale, the insider owned 15,431 shares in the company, valued at $2,298,293.14. This represents a 64.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 271,676 shares of company stock valued at $40,489,525 in the last ninety days. Company insiders own 0.12% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the company. UBS Group reiterated a “buy” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Morgan Stanley restated an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Robert W. Baird boosted their price objective on Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a research report on Wednesday, August 13th. Wells Fargo & Company restated an “overweight” rating and issued a $185.00 price objective (up from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Finally, Leerink Partners boosted their price objective on Cardinal Health from $186.00 to $187.00 and gave the company an “outperform” rating in a research report on Monday, October 6th. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $166.00.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.